Cargando…

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study

Biomarkers for the early diagnosis of pancreatic cancer (PC) are urgent needed. Plasma microRNAs (miRNAs) might be used as biomarkers for the diagnosis of cancer. We analyzed 361 plasma samples from 6 surgical centers in China and performed machine learning approach. We gain insight of the associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Zhe, Liu, Chang, Xu, Jianwei, You, Lei, Wang, Chunyou, Lou, Wenhui, Sun, Bei, Miao, Yi, Liu, Xubao, Wang, Xiaowo, Zhang, Taiping, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173079/ https://www.ncbi.nlm.nih.gov/pubmed/27223429 http://dx.doi.org/10.18632/oncotarget.9491

Ejemplares similares

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
por: Xiong, Guangbing, et al.
Publicado: (2019)

MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
por: Xu, Jianwei, et al.
Publicado: (2014)

Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review
por: Cao, Zhe, et al.
Publicado: (2015)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
por: Xu, Jianwei, et al.
Publicado: (2016)

Pancreatic panniculitis associated with pancreatic carcinoma: A case report
por: Zhang, Guannan, et al.
Publicado: (2016)

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
por: Zhang, Jingcheng, et al.
Publicado: (2019)

Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?
por: Feng, Mengyu, et al.
Publicado: (2019)

Clinical characteristics and prognosis of primary leiomyosarcoma of the pancreas: a systematic review
por: Xu, Jianwei, et al.
Publicado: (2013)

Analysis of clinical characteristics and treatment of pancreatic cystic tumors
por: You, Lei, et al.
Publicado: (2016)

CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
por: Wang, Tianxiao, et al.
Publicado: (2014)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
por: Liu, Xiaohui, et al.
Publicado: (2017)

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
por: Liu, Xiaohui, et al.
Publicado: (2018)

Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
por: Wu, Mengwei, et al.
Publicado: (2019)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer: A multicenter randomized clinical trial protocol
por: Dai, Menghua, et al.
Publicado: (2022)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

Long Term Outcomes of No-Touch Isolation Principles Applied in Pancreaticoduodenectomy for Treatment of Pancreatic Adenocarcinoma: A Multicenter Retrospective Study with Propensity Score Matching
por: Mou, Yu, et al.
Publicado: (2023)

MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy
por: Xiong, Junjie, et al.
Publicado: (2017)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

In silico and in vitro protocols for quantifying gene expression noise modulated by microRNAs
por: Wei, Lei, et al.
Publicado: (2022)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
por: Yuan, Wei, et al.
Publicado: (2016)

Management of late hemorrhage after pancreatic surgery: treatment strategy and prognosis
por: Wu, Xin, et al.
Publicado: (2020)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3
por: Wang, Chunyou, et al.
Publicado: (2016)

Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw
por: Yang, Rui, et al.
Publicado: (2018)

High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
por: Ren, Bo, et al.
Publicado: (2021)

A Single Talent Immunogenic Membrane Antigen and Novel Prognostic Predictor: voltage-dependent anion channel 1 (VDAC1) in Pancreatic Cancer
por: Wang, Weibin, et al.
Publicado: (2016)

Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis
por: Zheng, Zhenjiang, et al.
Publicado: (2019)

Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer
por: Zheng, Zhenjiang, et al.
Publicado: (2019)

Comparison of long-term benefits of organ-preserving pancreatectomy techniques for benign or low-grade malignant tumors at the pancreatic head
por: Li, Yatong, et al.
Publicado: (2017)

The dual functional role of MicroRNA-18a (miR-18a) in cancer development
por: Shen, Kexin, et al.
Publicado: (2019)

A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
por: Wang, Weibin, et al.
Publicado: (2018)

Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis
por: Xin, Lei, et al.
Publicado: (2017)

Association Between the Neutrophil-To-Lymphocyte Ratio and Diabetes Secondary to Exocrine Pancreatic Disorders
por: Chen, Guanhua, et al.
Publicado: (2022)

A Four-MicroRNA Panel in Peripheral Blood Identified as an Early Biomarker to Diagnose Acute Myocardial Infarction
por: Chen, Liang, et al.
Publicado: (2021)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qat0951dgos3hd3c2iihs8ohud